Asker Healthcare Group AB
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equip… Read more
Asker Healthcare Group AB (I88) - Total Assets
Latest total assets as of June 2025: €15.21 Billion EUR
Based on the latest financial reports, Asker Healthcare Group AB (I88) holds total assets worth €15.21 Billion EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Asker Healthcare Group AB - Total Assets Trend (2022–2024)
This chart illustrates how Asker Healthcare Group AB’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Asker Healthcare Group AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Asker Healthcare Group AB's total assets of €15.21 Billion consist of 34.2% current assets and 65.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.7% |
| Accounts Receivable | €1.73 Billion | 13.2% |
| Inventory | €1.82 Billion | 13.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.95 Billion | 14.9% |
| Goodwill | €5.10 Billion | 38.9% |
Asset Composition Trend (2022–2024)
This chart illustrates how Asker Healthcare Group AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Asker Healthcare Group AB's current assets represent 34.2% of total assets in 2024, an increase from 33.3% in 2022.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2024, up from 2.1% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 52.0% of total assets, a decrease from 56.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 38.9% of total assets.
Asker Healthcare Group AB Competitors by Total Assets
Key competitors of Asker Healthcare Group AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Asker Healthcare Group AB - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Asker Healthcare Group AB generates 1.15x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Asker Healthcare Group AB generates $ 2.74 in net profit.
Asker Healthcare Group AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.44 | 1.73 | - |
| Quick Ratio | 0.94 | 1.06 | - |
| Cash Ratio | 0.00 | 0.00 | - |
| Working Capital | €1.70 Billion | € 2.06 Billion | - |
Asker Healthcare Group AB - Advanced Valuation Insights
This section examines the relationship between Asker Healthcare Group AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.10 |
| Asset Growth Rate (YoY) | 15.8% |
| Total Assets | €13.12 Billion |
| Market Capitalization | $1.37 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Asker Healthcare Group AB's assets below their book value (0.10 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Asker Healthcare Group AB's assets grew by 15.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Asker Healthcare Group AB (2022–2024)
The table below shows the annual total assets of Asker Healthcare Group AB from 2022 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €13.12 Billion | +15.82% |
| 2023-12-31 | €11.33 Billion | +10.67% |
| 2022-12-31 | €10.23 Billion | -- |